Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 300 iu/ml equivalent to 10.91 mg/ml - solution for injection - 300 iu/ml - active: insulin glargine 300 iu/ml equivalent to 10.91 mg/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc chloride - treatment of diabetes mellitus in patients 6 years of age and older.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - laronidase 0.58 mg/ml (rch) - concentrate for infusion - 500 u/5ml - active: laronidase 0.58 mg/ml (rch) excipient: dibasic sodium phosphate monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - aldurazyme is indicated as long-term enzyme replacement therapy in patients with mucopolysaccharidosis i (mps i; alpha-l-iduronidase deficiency) to treat the non-neurological manifestations of the disease.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine 100mg - injection (depot) - 100 mg/0.5ml - active: buprenorphine 100mg excipient: n-methyl-2-pyrrolidone polyglactin - sublocade is indicated for maintenance treatment of opioid dependence, within a framework of medical, social and psychological treatment.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine 300mg - injection (depot) - 300 mg/1.5ml - active: buprenorphine 300mg excipient: n-methyl-2-pyrrolidone polyglactin - sublocade is indicated for maintenance treatment of opioid dependence, within a framework of medical, social and psychological treatment.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - eftrenonacog alfa 4000 [iu];   - powder for infusion - 4000 iu - active: eftrenonacog alfa 4000 [iu]   excipient: histidine hydrochloric acid mannitol polysorbate 20 sucrose sodium chloride water for injection - alprolix is a long-acting anti-haemophilic factor (recombinant) indicated in adults and children with haemophilia b (congenital factor ix deficiency) for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis)

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - elexacaftor 100mg;  ; ivacaftor 75mg;  ;  ; tezacaftor 50mg;  ;  ; ivacaftor 150mg - film coated tablet - active: elexacaftor 100mg   ivacaftor 75mg     tezacaftor 50mg     excipient: croscarmellose sodium hypromellose hypromellose acetate succinate magnesium stearate microcrystalline cellulose opadry orange 20a130039 sodium laurilsulfate active: ivacaftor 150mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium hypromellose acetate succinate lactose monohydrate magnesium stearate microcrystalline cellulose opacode black s-1-17823 opadry blue 85f90614 sodium laurilsulfate - trikafta is indicated for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - elexacaftor 50mg;  ; ivacaftor 37.5mg;  ;  ; tezacaftor 25mg;  ;  ; ivacaftor 75mg - film coated tablet - active: elexacaftor 50mg   ivacaftor 37.5mg     tezacaftor 25mg     excipient: croscarmellose sodium hypromellose hypromellose acetate succinate magnesium stearate microcrystalline cellulose opadry orange 20a130039 sodium laurilsulfate active: ivacaftor 75mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium hypromellose acetate succinate lactose monohydrate magnesium stearate microcrystalline cellulose opacode black s-1-17823 opadry blue 85f105098 sodium laurilsulfate - trikafta is indicated for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - neisseria meningitidis group a polysaccharide 10ug (conjugated to tetanus toxoid); neisseria meningitidis group c polysaccharide 10ug (conjugated to tetanus toxoid); neisseria meningitidis group w135 polysaccharide 10ug (conjugated to tetanus toxoid); neisseria meningitidis group y polysaccharide 10ug (conjugated to tetanus toxoid) - solution for injection - 0.5 ml - active: neisseria meningitidis group a polysaccharide 10ug (conjugated to tetanus toxoid) neisseria meningitidis group c polysaccharide 10ug (conjugated to tetanus toxoid) neisseria meningitidis group w135 polysaccharide 10ug (conjugated to tetanus toxoid) neisseria meningitidis group y polysaccharide 10ug (conjugated to tetanus toxoid) excipient: sodium acetate sodium chloride tetanus toxoid water for injection - menquadfi is indicated for active immunisation for the prevention of invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w and y. the use of menquadfi should be in accordance with official recommendations.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 10.91 mg/ml equivalent to 300 iu/ml - solution for injection - 300 iu/ml - active: insulin glargine 10.91 mg/ml equivalent to 300 iu/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc chloride - treatment of diabetes mellitus in adults.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin aspart 100 u/ml (3.5 mg/ml) - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml (3.5 mg/ml) excipient: hydrochloric acid metacresol phenol polysorbate 20 sodium chloride sodium hydroxide water for injection zinc chloride - treatment of diabetes mellitus